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Abstract Nursing home-acquired pneumonia (NHAP) is
one of the most common infections arising amongst nurs-
ing home residents, and its incidence is expected to
increase as population ages. The NHAP recommendation
for empiric broad-spectrum antibiotic therapy, arising from
the concept of healthcare-associated pneumonia, has been
challenged by recent studies reporting low rates of mul-
tidrug-resistant (MDR) bacteria. This single center study
analyzes the results of NHAP patients admitted through the
Emergency Department (ED) at a tertiary center during the
year 2010. There were 116 cases, male gender corre-
sponded to 34.5 % of patients and median age was
84 years old (IQR 77–90). Comorbidities were present in
69.8 % of cases and 48.3 % of patients had used healthcare
services during the previous 90 days. In-hospital mortality
rate was 46.6 % and median length-of-stay was 9 days.
Severity assessment at the Emergency Department pro-
vided CURB65 index score and respective mortality (%)
results: zero: n = 0; one: n = 7 (0 %); two: n = 18
(38.9 %); three: n = 26 (38.5 %); four: n = 30 (53.3 %);
and five; n = 22 (68.2 %); and sepsis n = 50 (34.0 %),
severe sepsis n = 43 (48.8 %) and septic shock n = 22
(72.7 %). Significant risk factors for in-hospital mortality
in multivariate analysis were polypnea (p = 0.001),
age C 75 years (p = 0.02), and severe sepsis or shock
(p = 0.03) at the ED. Microbiological testing in 78.4 % of
cases was positive in 15.4 % (n = 15): methicillin-
resistant Staphylococcus aureus (26.7 %), Pseudomonas
aeruginosa (20.0 %), S. pneumoniae (13.3 %), Escherichia
coli (13.3 %), others (26.7 %); the rate of MDR bacteria
was 53.3 %. This study reveals high rates of mortality and
MDR bacteria among NHAP hospital admissions support-
ing the use of empirical broad-spectrum antibiotic therapy
in these patients.
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Introduction
Pneumonia is one of the most common infections arising
amongst nursing home residents [1]. Nursing home-ac-
quired pneumonia (NHAP) is a concept emerging from
within the definition of Health-case associated Pneumonia
(HCAP) and is an entity frequently presenting to the
Emergency Department (ED) requiring hospital admission.
Patients suffering from this condition are typically of older
age, and present a high burden of comorbid conditions. The
presence of multi-resistant drug (MRD) pathogens, espe-
cially methicillin-resistant Staphylococcus aureus (MRSA)
and Pseudomonas aeruginosa, is a major concern [2]. For
these reasons increased mortality is expected when com-
pared to other types of pneumonia.
The Portuguese population has importantly aged with
19.3 % of the people in the age group C65 years old,
representing a 19.0 % relative increase between 2001 and
2011 [3]. Furthermore the incidence of Community-ac-
quired Pneumonia (CAP) hospital admissions has also been
reported to have increased 28.2 % between the first and the
second half of the past decade [4]. Therefore, the number
of nursing home residents and the frequency of NHAP
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should also be expected to increase, although current data
on its incidence are scarce.
The authors aimed to analyze incidence, microbiological
results, outcomes and risk factors in NHAP admissions at a
tertiary hospital center during the year 2010.
Methods
The was a retrospective cohort study of all adult patients
admitted through the Emergency Department (ED) with a
primary diagnosis of Pneumonia at Centro Hospitalar Lis-
boa Central (CHLC), E.P.E., a Portuguese tertiary Hospital
Center located in Lisbon’s metropolitan area, during the
period between 1st January and 31st December of 2010.
Pneumonia diagnostic codes (International Classifica-
tion of Diseases—9: 480–488) were searched for in the
institutional database. ‘‘Pneumonia’’ was defined as hos-
pital admission for acute lower respiratory tract infection
associated with de novo radiographic shadowing during the
initial 48 h for which there was no other explanation, and
was clinically managed as such [5].
Pneumonia episodes were screened for clinical and
radiological criteria and selected if these were fulfilled to
build a cohort. Patients with nursing home residence were
then screened and included in this study. Hospital dis-
charge in the previous 10 days was an exclusion criteria
considering re-admission of the same illness or nosocomial
pneumonia etiology.
‘‘Comorbidity’’ was considered as any prior history of
chronic organic illness, solid or hematologic neoplasm and
‘‘anemia’’: hematocrit \30 %. For risk factor analysis
‘‘Confusion’’ was considered as any acutely altered state of
conscience; ‘‘polypnea’’: respiratory rate [20 cycles/min
or clinical reference to dyspnea, polypnea, or tachypnea;
‘‘hypoxemia’’: peripheral blood oxygen saturation\90 %
or arterial blood oxygen pressure\60 mmHg; ‘‘tachycar-
dia’’: cardiac rate[125 beats/min; ‘‘hypotension’’: systolic
blood pressure \90 mmHg or diastolic \60 mmHg; and
‘‘nursing home’’: patient resident at a non-hospital long-
term care facility.
Microbiological results considered cultural results from
products obtained during the initial 48 h from ED admis-
sion, as well as urinary antigens for Legionella pneu-
mophila and Streptococcus pneumoniae and H1N1
influenza PCR throughout the entire hospital stay.
True bacteriemia was considered as described by
Weinstein et al. and cited in the literature [6].
All clinical and laboratory results were obtained from
the initial approach at the ED, as well as severity of illness
scoring using CURB65 index score [7] and the revised
Sepsis classification criteria [8].
To compare NHAP CURB65 discriminative ability for
in-hospital death prediction we used data from the group of
CAP patients derived from the same original cohort [9].
Statistical tests for data analysis included binomial test
for proportion, Fisher’s exact Chi-square test for contin-
gency tables, Mann–Whitney test for median values com-
parison, Kruskal–Wallis test for multiple independent
variable and receiver operator curve (ROC) for CURB65
index score analysis. Risk associated variables with p value
B0.15 were included in multivariable analysis. Binary
logistic regression using backward method with probability
for stepwise removal [0.1 was used for multivariable
analysis. Area under the curve (AUC) and significance of
the difference between the areas under two independent
ROC Curves were analyzed as cited in the literature [10,
11]. Statistical significance was considered when double
sided p value was B0.05. Confidence intervals of 95 % (CI
95 %) were used for odds ratio (OR) and AUC. Statistical
software OpenEpi (Center for Disease Control and
Prevention, Atlanta, GA, EUA) and ‘‘Statistical Package
for the Social Sciences’’ v17.0. (IBM SPSS, Ill. EUA)
were used for data analyzes.




During the study period there were 29,684 adult hospital
admissions from which 1635 had a Pneumonia diagnosis.
Eight hundred and eighty two cases were excluded due to:
alternative primary admission diagnosis (n = 272), lack of
digital clinical records (n = 169), repetition (n = 140),
hospital discharge within the 10 previous days (n = 85),
absence of radiologic shadowing (n = 65), radiologic
exams unavailable (n = 25) and other reasons (n = 125)
including unknown reason for admission, patient not
admitted via ED and age under 15 years old.
There were 753 cases of hospital admission due to
pneumonia selected for this cohort and 116 cases of NHAP
were included in this study analysis [9].
Epidemiology
Temporal distribution of cases showed bimodal peak
incidence in March and July (both 12.1 %) and low in May
and December (both 1.7 %).
Male gender corresponded to 34.5 % (n = 40) of the
study sample (p\ 0.001). Median age was 84 years old
[interquartile range (IQR) 77–90]. Male median age was
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80 years old (IQR 75–86) while female median age was 87
(IQR 83–91).
There were comorbidities in 69.8 % (n = 81) of cases,
including heart failure (n = 35), cerebral vascular disease
(n = 33), anemia (n = 30), diabetes mellitus (n = 22),
lung disease (n = 17), renal failure (n = 13), history of
neoplasm (n = 9) and liver disease (n = 1).
During the prior 90 days (admissions within the prior
10 days excluded) 48.3 % of these patients had reportedly
had healthcare services: 34.5 % had been to ED consulta-
tion, 27.6 % had taken antibiotic therapy [penicillin deri-
vates (n = 19), cephalosporin (n = 7), quinolone (n = 3),
sulfonamides (n = 2) and macrolide (n = 1)] and 20.7 %
had had hospital admission stay.
Patient characteristics are described in Table 1.
Microbiology
Microbiological testing for etiology was performed in
78.4 % (n = 91) of cases yielding a positive result in
15.4 %.
Blood cultures were performed in 83 cases with bac-
teriemia in 12.0 % and contamination in 2.4 %. Respira-
tory secretions were collected for culture in 17 cases with
agent isolation in 23.5 %, contamination in 23.5 % and
inadequate sampling in 23.5 %. Urinary antigens for L.
pneumophila and Streptococcus pneumoniae were searched
in 30 and 26 cases, respectively, and H1N1 Influenza virus
respiratory swab was taken for PCR analysis in two cases
with no positive results.
Identified etiologic agents (n = 15) were: MRSA
(26.7 %), Pseudomonas aeruginosa (20.0 %), S. pneumo-
niae (13.3 %), Escherichia coli (13.3 %), Haemophilus
influenzae (6.7 %), Enterococcus faecalis (6.7 %), Sta-
phylococcus capitis (6.7 %) and Streptococcus agalactiae
(6.7 %). P. aeruginosa and H. influenzae isolations were
obtained from respiratory secretions.
Of these isolated agents 53.3 % were MDR pathogens
[four MRSA, three P. aeruginosa and one extended spec-
trum beta-lactamase (ESBL) producing E. coli].
Hospital results
Overall in-hospital mortality rate was 46.6 % (n = 54).
Median length-of-stay was 9 days (P25 = 5; P75 = 13).
Male mortality was 40.0 % and female 50.0 %. The
median of age for the deceased was 86 years old (IQR
82–91) and 83 (IQR 75–88) for survivors. Mortality in the
presence of comorbidities was 45.7 % versus 48.6 % in its
absence. Comparison of survivor and non-survivor char-
acteristics is described in Table 2.
Sepsis criteria were confirmed in 115 cases with 43.1 %
sepsis, 37.1 % severe sepsis and 19.0 % septic shock and
matching mortality rates of 34.0, 48.8 and 72.7 %.
Severity of illness case distribution by CURB65 index
score (n = 103) and respective 30 day mortality rates,
illustrated in Graphic 1, were as follows: zero (n = 0); one
(n = 7), 0 %; two (n = 18), 38.9 %; three (n = 26),
38.5 %; four (n = 30), 53.3 %; and five (n = 22); 68.2 %
(p = 0.02 between groups);with a respective ROC AUC of
0.673 (IC 95 % 0.569–0.776).
When comparing CURB65 AUC ROC discriminative
ability for outcome prediction in NHAP to the CAP group
(0.789; IC 95 % 0.724–0.854; n = 314) from the same
cohort the result was not significantly inferior (p = 0.1).
Risk factors
Significant risk factors for in-hospital death in univariate
analysis were polypnea (p\ 0.001), hypotension
(p = 0.04), severe sepsis or shock (p = 0.01), age C75
years (p = 0.04) (Table 2). In multivariable analysis
association with mortality was significant for variables
polypnea (p = 0.001), age C 75 years (p = 0.02), and
severe sepsis or shock (p = 0.03) (Table 3).
The presence of MDR pathogens was associated in
univariate analysis with severe sepsis or shock (p = 0.04),
hypotension (p = 0.04) and confusion (p = 0.04). In
multivariate analysis none of these associations reached
significance.
Table 1 Nursing home-acquired pneumonia patient characteristics
n = 116 % n
Female gender 65.5 76
Age (years, median) 84.0 IQR 77–90










Previous healthcare contact 48.3 56
ED consult 34.5 40
Antibiotic therapy 27.6 32
Hospitalization 20.7 24
Overall mortality (%) 46.6 54
IQR interquartile range, ED emergency department
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Survivors (n = 62) Non-survivors (n = 54) p value
n % n %
Male gender 24 38.7 16 25.8 0.33
Age (years; median) 83 IQR 75–88 86 IQR 82–91 0.01
Hospital stay (days; median) 10 IQR 8–15 5 IQR 2–10 \0.001
Comorbidities (overall) 44 71.0 37 68.5 0.84
Cardiac 17 28.3 18 34.6 0.54
Cerebrovascular 21 34.4 12 23.5 0.22
Anemia 13 21.0 17 32.7 0.20
Diabetes mellitus 15 24.2 7 13.0 0.16
Pulmonary 9 15.0 8 16.0 1.00
Renal 5 8.3 8 15.1 0.38
Neoplasm 3 4.9 6 11.3 0.30
Liver 0 1 2.0
Previous healthcare contact 30 48.4 26 48.1 1.0
ED consultation 20 32.3 20 37.7 0.56
Antibiotic therapy 19 31.1 13 26.0 0.67
Hospitalization 11 17.7 13 24.1 0.49
Confusion 37 59.7 38 73.1 0.17
Urea[40 mg/dL 44 72.1 43 81.1 0.18
Polypnea 24 43.6 41 78.8 \0.001
Hypotension 20 32.3 28 51.9 0.04
Age[75 years 48 77.4 50 92.6 0.04
Tachycardia 37 59.7 39 72.2 0.17
Creatinine[1.20 mg/dL 18 29.0 23 44.2 0.12
Severe sepsis/shock 28 45.2 37 68.5 0.01
IQR interquartile range, ED Emergency Department
0 1 2 3 4 5
Frequency 0 7 18 26 30 22





























Graphic 1 CURB65 index
score and 30 day in-hospital






There are limitations to this study, namely the absence of
(1) a standard clinical procedure protocol, including (2)
serological or PCR research for atypical etiologic agents;
(3) antibiotic therapy prescription analysis, (4) time inter-
val analysis between ED admission and antibiotic admin-
istration (these last two with an impact on survival), (5)
potential admission bias and (6) single center data pre-
cluding the generalizability of results.
Discussion
During the study period Hospital Center Lisboa Central
(CHLC) included hospitals Sa˜o Jose´, Santo Anto´nio dos
Capuchos and Santa Marta caring for a population of
approximately 191.000 adults with a high proportion
(24.2 %) of people aged C65 years old [3].
In our study the typical NHAP patient profile was ren-
dered by a clear predominance of the female gender,
advanced age and preexisting comorbidities, with more
than one-third of the study population having had health-
care services during the prior 3 months indicating a
somewhat expected decaying health status and high use of
healthcare resources.
Hospital results showed high mortality rates particularly
among the most advanced ages and most severely ill
patients, which could be interpreted in the light of the
vulnerability of this population due to comorbidities and
extremes of age conveying limited organic functional
reserve and end-of life pneumonia. In selected cases
admission to Intensive Care and mechanical ventilation
may have been limited although this was not assessed in
our study.
Clinical severity of illness assessment tools, Sepsis
criteria and CURB-65, were useful at the ED discrimi-
nating risk groups for outcome. Several studies have
demonstrated the usefulness of CURB65 in NHAP and
HCAP [12–14] although it may show reduced discrimi-
nating ability as compared to its original use in CAP
populations. This is demonstrated in our study by a non-
significant inferior CURB65 ROC AUC comparison result
between NHAP and CAP groups derived from the same
original cohort [9].
Multivariate analysis for significant in-hospital mortality
risk factors revealed association with polypnea, age
C75 years old and severe sepsis or shock at the ED all of
which is to be expected. Regarding risk factors for isolation
of MDR pathogens no significant associations were
unveiled possibly due to the small number of patients.
The most frequently isolated agents in this study were
MRSA and P. aeruginosa and over half of all isolated
bacteria were MDR. This observation is of the utmost
importance due to implications on initial patient approach
and initial empirical therapy.
Previous fundamental works have addressed NHAP
within the HCAP definition considering high risk of MDR
pathogens, namely MRSA and P. aeruginosa, and recom-
mend empirical treatment with broad-spectrum antibiotic
therapy, as opposed to CAP [18, 19]. A major concern
regarding this approach is the overuse of empirical broad-
spectrum antibiotics and the development of further bac-
terial resistance to these therapeutical agents.
Recent studies report S. pneumoniae as one of the
principal etiological NHAP agent, as well as indicate a low
prevalence of MDR pathogens and question the recom-
mendation to treat these patients with empirical broad-
spectrum antibiotics [15–18].
Research data from both HCAP and NHAP populations
have provided with heterogeneous microbiological results
and thus failed so far to produce changes in current treat-
ment recommendations. The issue here concerned may be
the importance of understanding local realities and adapt-
ing to them. It is possible that part of the heterogeneity of
microbiological results in NHAP studies reflect differences
in study methodologies and regional contrasts regarding
socio-economic and healthcare factors affecting nursing
home resident populations (What is the nursing home user
profile? How is the quality of nursing and medical assis-
tance and antibiotic prescription?). Our study aimed to
analyze NHAP from an in-patient perspective and does not
focus on the questions regarding the out-patient and the
quality of nursing home care.
We believe that current NHAP recommendations for
aggressive empirical broad-spectrum antibiotic therapy
should apply to our study population as suggested by the
high rates of mortality and MDR bacteria observed. The
importance of clinical pro-active etiological investigation
to guide individual treatment options and provide epi-
demiologic data must be stressed at this point. NHAP
should be regarded as a separate entity from HCAP and
investigation (including both in-patients and out-patients to
avoid admission bias) should be encouraged for the
development of tailored therapeutic strategies.
Table 3 Multivariable backward stepwise logistic regression for in-
hospital mortality associated risk factors
p value Odds ratio 95 % CI
Polypnea 0.001 5.1 2.0 12.7
Age C75 years 0.02 4.5 1.2 16.6
Severe sepsis or shock 0.03 2.7 1.1 6.6
Creatinine[1.20 mg/dL 0.08 2.3 0.9 5.9
Two step analysis. Variable hypotension removed from model due to




In this NHAP study in-hospital mortality was very high and
associated with extremes of age, polypnea and severe
sepsis or shock at the ED. The most frequent pathogens
were MRSA and P. aeruginosa and the majority of isolated
bacteria were MDR supporting the recommendations for
empirical broad-spectrum antibiotic therapy. Understand-
ing NHAP as a separate entity is crucial and further
research should lead to the development of tailored thera-
peutic strategies.
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